Tumor RNA sequencing analysis confirmed pathways of inflammation and CD4 and CD8 T-cell activation to be common between the PD-1 ab-treated and PD-1cKO mice and a dominant IFNγ response in the tumor microenvironment. The gene discussed is PDCD1; the disease is neoplasm.